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mice but not in the FGF21-KO diabetic mice. Mechanistic study with
H9C2 cells in vitro showed that autophagy, measured by cytoplasmic
form microtubule-associated protein 1A/1B-light chain 3 (LC3)
expression, was signiﬁcantly inhibited by high glucose (HG, 30 mM)
that also signiﬁcantly increased inﬂammation, oxidative stress, and
ﬁbrosis. These HG effects were prevented by FF treatment. Inhibi-
tion of autophagy by 3-methyladenine (3MA) or inhibition of Sirt1 by
sirtinol abolished FF protection against HG-induced effects.
Together, these results suggested that FF could prevent DCM
by inducing FGF21, which in turn enhances the Sirt1-mediated
autophagy.GW26-e1079
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OBJECTIVES Excessive retention of neutral lipids in cardiac lipid
droplets (LDs) is a common observation in cardiomyopathy. We
anticipate that the systematic investigation of the cardiac LD prote-
ome will help to dissect the underlying mechanisms linking cardiac
steatosis and myocardial dysfunction.
METHODS LDs isolated from Sprague-Dawley rat hearts were
analyzed using morphological and biochemical approaches and then
subjected to iTRAQ quantitative proteomic analysis. The LD localiza-
tion of the identiﬁed LD proteins was veriﬁed by immunoﬂuorescence
assays. The set of dysferlin truncation mutants were used to deter-
mine the LD-binding structure.
RESULTS 771 heart LD proteins were identiﬁed and categorized into
10 functional groups, including 467 proteins previously unreported
on LDs. The LD localization of these proteins was veriﬁed by
immunoﬂuorescence assays. The most noteworthy ﬁnding was the
identiﬁcation of the membrane resealing protein, dysferlin. An
analysis of dysferlin truncation mutants indicated that its C2
domain was responsible for its LD localization. Using the iTRAQ
quantitative proteomic method we determined that the quantity of
30 proteins was increased and 16 proteins was decreased in LDs
from pressure overload-induced dysfunctional heart, compared with
normal hearts. Notably, adipose triacylglycerol lipase (ATGL) was
dramatically decreased and dysferlin was substantially increased
on dysfunctional cardiac LDs, a ﬁnding that was conﬁrmed using
immunoblotting.
CONCLUSIONS This study for the ﬁrst time reveals the dataset of the
heart LD proteome in healthy tissue and the variation of it under
cardiac dysfunction. These ﬁndings highlight an association between
the altered LD proteinlocalization of dysferlin and ATGL and
myocardial dysfunction.GW26-e1360
Effects of Sirt1 on Protection Against Atherosclerosis Plaque via
Anti-angiogenesis in Mice
Zhenhua Jiang,1 Sai Ma,1 Dong Han,1 Jiangwei Chen,1 Ran Zhang,1
Feng Cao2,1
1Department of Cardiology, Xijing Hospital, Fourth Military Medical
University, Xi’an, Shaan Xi, China; 2Cardiology Department, Chinese
PLA General Hospital, Beijing, China
OBJECTIVES Atherosclerosis (AS) is an age-related disease attributed
to vascular endothelial cell injury Angiogenesis might contribute to
the progression of the atherosclerotic plaque SIRT1, has been reported
to have the function of anti-angiogenesis and prevent senescence In
this report, the present study aims to investigate whether resveratrol,
an activator of SIRT1, is capable of protecting against atherosclerosis
progress via anti-angiogenesis.
METHODS 25 Apolipoprotein E–knockout mice were divided into
three groups: control group (n ¼5) with normal diet, high-fat diet
(HFD) group (n¼10) for 16 weeks, high-fat diet(16 weeks)+ resveratrol
(2 months) group (HFD+RES) (n¼10) following with resveratrol intra-
peritoneal injection (100 mg/kg/day, i.p) for two months Body weight,
serum total cholesterol(TC), triglyceride(TG), LDL-C, HDL-C level and
oil red O stain were performed to determine the establishment ofatherosclerosis model. Immunoﬂuorescence staining of CD31 was
used to detect angiogenesis in atherosclerotic plaque. In vitro HUVECs
study included six groups: control group, H2O2 treated group (HO),
H2O2+resveratrol group (HO+ RES), sh-SIRT1 group, sh-SIRT1+ H2O2
group (sh-SIRT1+HO) and sh-SIRT1+ H2O2+ resveratrol group (sh-
SIRT1+ HO+ RES) Oxidative stress damage was induced by H2O2.
HUVECs proliferation was evaluated with wound assay and transwell
migration assay. HUVECs apoptosis was assessed with TUNEL. Intra-
cellular production of reactive oxygen species (ROS) was detected by a
ﬂuorescence probe–20,70–dichloroﬂuorescin diacetate (DCFH–DA).
Subsequently, Western Blot was performed to determine relative
changes of proteins such as SIRT1, HIF-1a and VEGF. We also explored
the dose-dependent effect of resveratrol on HUVECs subjected to
oxidative stress.
RESULTS As compared with control group mice, HFD mice showed
increased body weight, serum TC, TG, LDL-C level and reduced
HDL-C. The size of tissues positive for oil red O expression
was higher in the HFD mice (P<0.05), indicating the model of AS
was established successfully. Subsequently, immunoﬂuorescence
staining of CD31 showed that angiogenesis in HFD+RES group
signiﬁcantly decreased compared with the HFD only group, indi-
cating that resveratrol was capable of inhibiting angiogenesis in AS
plaque. In vitro results revealed that H2O2 induced oxidative stress
damage on HUVECs, evidenced by increased ROS generation.
Furthermore, HIF-1a and VEGF expression were increased whereas
SIRT1 expression was reduced (P<0.05). Resveratrol reversed these
changes in HO group, however this effect was diminished in
sh-SIRT1+ HO group. Moreover, high-concentration resveratrol
inhibited tube formation and cell migration in HUVECs by contrib-
uting to apoptosis (P<0.05).
CONCLUSIONS High-concentration resveratrol protects against
atherosclerosis and improves vascular function in HFD mice through
anti-angiogenesis in plaque. SIRT1 plays an important role in the
resveratrol beneﬁcial effects against atherosclerosis.GW26-e1553
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OBJECTIVES Current studies show that ivabradine, a speciﬁc heart
rate lowering drug, it selective inhibitor of funny (If), performing anti-
arrhythmic effect of some disease condition, such as heart failure,
myocardial ischemia, and so on. But little is known regarding the
long-term ivabradine treatment on If current and prevention of atrial
ﬁbrillation (AF).
METHODS We ﬁrstly investigated the If current and the HCN channels
expression between the wild-type (WT) mice and the transgenic mice
overexpressing heart-speciﬁc (pro) renin receptor (TG), a useful
mouse model of AF, and then examined the effects of ivabradine on
the If current and HCN channels expression, and the prevention of AF
episode.
RESULTS Compared with WT mice, the enhanced If current density
(at -170mV: TG, -39.64.6pA/pF; WT, -26.93.0pA/pF, p<0.001) and
the faster activation kinetic (V1/2: TG, -109.451.35 mV; WT,
-128.201.65 mV), as well as the mRNA of HCN2 and HCN4, accom-
panying the HCN4 protein were signiﬁcantly increased in atrial
myocytes from TG mice. After treatment with ivabradine for 4 months
(7mg/kg per day orally), it partially reverses the electrophysiological
remodeling occurring in TG mice, and If density was reduced in the
atrial myocytes (at -170mV: TG, -17.73.0pA/pF; WT, -18.03.1pA/pF,
p¼0.89). The effects of ivabradine on electrophysiological remodeling
were accompanied by an inhibition of upregulation of HCN2 and
HCN4 protein in atrium tissue. Furthermore, we found that ivabradine
signiﬁcantly reduce the incidence of AF among TG mice (41.2% in TG
mice, 16.7% in TG+ivabradine mice, p<0.01), most likely by sup-
pressing an increase in automaticity.
CONCLUSIONS Thus, our ﬁndings provide the ﬁrst evidence that
ivabradine reduced the incidence of AF in mice, and the anti-
arrhythmic of ivabradine was beyond the hate rate reduction, it
partially due to counteract the HCN overexpression and reverse elec-
trophysiological cardiac remodeling by reducing If gain-of-function.
